342 related articles for article (PubMed ID: 23519462)
21. On the relationship between glucose absorption and glucose-stimulated secretion of GLP-1, neurotensin, and PYY from different intestinal segments in the rat.
Kuhre RE; Christiansen CB; Saltiel MY; Wewer Albrechtsen NJ; Holst JJ
Physiol Rep; 2017 Dec; 5(23):. PubMed ID: 29199179
[TBL] [Abstract][Full Text] [Related]
22. Dynamin regulates L cell secretion in human gut.
Sun EW; Matusica D; Wattchow DA; McCluskey A; Robinson PJ; Keating DJ
Mol Cell Endocrinol; 2021 Sep; 535():111398. PubMed ID: 34274446
[TBL] [Abstract][Full Text] [Related]
23. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
[TBL] [Abstract][Full Text] [Related]
24. The Noncaloric Sweetener Rebaudioside A Stimulates Glucagon-Like Peptide 1 Release and Increases Enteroendocrine Cell Numbers in 2-Dimensional Mouse Organoids Derived from Different Locations of the Intestine.
van der Wielen N; Ten Klooster JP; Muckenschnabl S; Pieters R; Hendriks HF; Witkamp RF; Meijerink J
J Nutr; 2016 Dec; 146(12):2429-2435. PubMed ID: 27798332
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II Type 1 Receptor-Dependent GLP-1 and PYY Secretion in Mice and Humans.
Pais R; Rievaj J; Larraufie P; Gribble F; Reimann F
Endocrinology; 2016 Oct; 157(10):3821-3831. PubMed ID: 27447725
[TBL] [Abstract][Full Text] [Related]
26. Chylomicrons stimulate incretin secretion in mouse and human cells.
Psichas A; Larraufie PF; Goldspink DA; Gribble FM; Reimann F
Diabetologia; 2017 Dec; 60(12):2475-2485. PubMed ID: 28866808
[TBL] [Abstract][Full Text] [Related]
27. SCFAs strongly stimulate PYY production in human enteroendocrine cells.
Larraufie P; Martin-Gallausiaux C; Lapaque N; Dore J; Gribble FM; Reimann F; Blottiere HM
Sci Rep; 2018 Jan; 8(1):74. PubMed ID: 29311617
[TBL] [Abstract][Full Text] [Related]
28. The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo.
Panaro BL; Tough IR; Engelstoft MS; Matthews RT; Digby GJ; Møller CL; Svendsen B; Gribble F; Reimann F; Holst JJ; Holst B; Schwartz TW; Cox HM; Cone RD
Cell Metab; 2014 Dec; 20(6):1018-29. PubMed ID: 25453189
[TBL] [Abstract][Full Text] [Related]
29. Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.
Nunez DJ; Bush MA; Collins DA; McMullen SL; Gillmor D; Apseloff G; Atiee G; Corsino L; Morrow L; Feldman PL
PLoS One; 2014; 9(4):e92494. PubMed ID: 24699248
[TBL] [Abstract][Full Text] [Related]
30. Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells.
Hodge D; Glass LL; Diakogiannaki E; Pais R; Lenaghan C; Smith DM; Wedin M; Bohlooly-Y M; Gribble FM; Reimann F
Peptides; 2016 Mar; 77():16-20. PubMed ID: 26144594
[TBL] [Abstract][Full Text] [Related]
31. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884
[TBL] [Abstract][Full Text] [Related]
32. A Mechanistic Study on Nanoparticle-Mediated Glucagon-Like Peptide-1 (GLP-1) Secretion from Enteroendocrine L Cells.
Beloqui A; Alhouayek M; Carradori D; Vanvarenberg K; Muccioli GG; Cani PD; Préat V
Mol Pharm; 2016 Dec; 13(12):4222-4230. PubMed ID: 27934480
[TBL] [Abstract][Full Text] [Related]
33. Bidirectional GPR119 Agonism Requires Peptide YY and Glucose for Activity in Mouse and Human Colon Mucosa.
Tough IR; Forbes S; Herzog H; Jones RM; Schwartz TW; Cox HM
Endocrinology; 2018 Apr; 159(4):1704-1717. PubMed ID: 29471473
[TBL] [Abstract][Full Text] [Related]
34. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
[TBL] [Abstract][Full Text] [Related]
35. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways.
Lan H; Lin HV; Wang CF; Wright MJ; Xu S; Kang L; Juhl K; Hedrick JA; Kowalski TJ
Br J Pharmacol; 2012 Apr; 165(8):2799-807. PubMed ID: 22029751
[TBL] [Abstract][Full Text] [Related]
36. Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas.
Kuhre RE; Wewer Albrechtsen NJ; Larsen O; Jepsen SL; Balk-Møller E; Andersen DB; Deacon CF; Schoonjans K; Reimann F; Gribble FM; Albrechtsen R; Hartmann B; Rosenkilde MM; Holst JJ
Mol Metab; 2018 May; 11():84-95. PubMed ID: 29656109
[TBL] [Abstract][Full Text] [Related]
37. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults.
Chambers ES; Viardot A; Psichas A; Morrison DJ; Murphy KG; Zac-Varghese SE; MacDougall K; Preston T; Tedford C; Finlayson GS; Blundell JE; Bell JD; Thomas EL; Mt-Isa S; Ashby D; Gibson GR; Kolida S; Dhillo WS; Bloom SR; Morley W; Clegg S; Frost G
Gut; 2015 Nov; 64(11):1744-54. PubMed ID: 25500202
[TBL] [Abstract][Full Text] [Related]
38. Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.
Evans S; Pamuklar Z; Rosko J; Mahaney P; Jiang N; Park C; Torquati A
Surg Endosc; 2012 Apr; 26(4):1086-94. PubMed ID: 22044971
[TBL] [Abstract][Full Text] [Related]
39. Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY.
Schmidt PT; Ljung T; Hartmann B; Hare KJ; Holst JJ; Hellström PM
Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):207-12. PubMed ID: 15674099
[TBL] [Abstract][Full Text] [Related]
40. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man.
Wettergren A; Petersen H; Orskov C; Christiansen J; Sheikh SP; Holst JJ
Scand J Gastroenterol; 1994 Jun; 29(6):501-5. PubMed ID: 7915853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
